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Familial amyloidosis cutis dyschromica
Ayşe Serap KARADAĞ1, Gülçin GÜLER ŞİMŞEK2

Abstract: Primary cutaneous amyloidosis is a rare progressive disease that is characterized with the deposition of amyloid
under the skin instead of internal organs. Major types are the macular, papular, nodular types. Amyloidosis cutis
dyschromica is a very rare specific type of vitiliginous amyloidosis. A 16 year-old female patient and 22 year-old male
patient, siblings, referred to the hospital with the complaint of non-pruritic diffuse hyperpigmentation beginning from
trunk and spreading to all body. The histopathologic findings and crystal violet stain were consistent with amyloidosis
cutis dyschromica. All other investigations were normal. There are few reported cases related with this amyloidosis type
and it was seldom reported as familial. This case is the first familial case from Turkey.
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Ailesel amiloidozis kutis diskromika
Özet: Primer kutanöz amiloidozlar nadir görülen, ilerleyici bir hastalık olup, amiloidin iç organlarda depolanmadan
deride depolanması ile karakterizedir. Başlıca maküler, papüler, nodüler tipleri görülmektedir. Amiloidozis kutis
diskromika vitiliginöz amiloidozisin çok nadir görülen, spesifik bir tipidir. Kardeş olan 16 yaşında bir bayan hasta ve 22
yaşında bir erkek hasta, gövdede başlayıp tüm vücuda yayılan kaşıntısız, difüz hiperpigmentasyon nedeniyle hastanemize
başvurdu. Histopatolojik bulgular ve kristal viyole boyası amiloidozis kutis diskromika ile uyumluydu. Diğer tüm tetkikler
normaldi. Bildirilen az sayıda olgu bulunmaktadır ve familyal olanları oldukça nadirdir. Bu olgu Türkiye’den bildirilen
ilk ailesel vakadır.
Anahtar sözcükler: Kutanöz amiloidoz, diskromik amiloidoz, primer amiloidoz

Introduction
Primary cutaneous amyloidosis is a rare progressive disease of the apparently normal skin that
is associated with the deposition of amyloid under the skin instead of internal organs. Major types
are macular, papular (lichen), and nodular (tumefactive) ones. Amyloidosis cutis dyschromica
(ACD) is a rare, primary localized cutaneous, vitiligous type of the amyloidosis (1,2). There are
few reported cases but it was seldom reported as familial (1,3). This case is the first familial case
from Turkey.
Case 1
A 16 year-old female patient referred to the hospital with the complaint of non-pruritic diffuse
hyperpigmentation beginning from trunk and spreading to all body. There was not intensive sun
exposure. She did not have any systemic or cutaneous disease. Her parents are cousins. Two children
of the family are sick, and the 3rd one is not.
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In the dermatological examination, there was a
diffuse hyperpigmentation with numerous spotted and
hypopigmented macules that were located on both
lower and upper extremities, trunk, buttocks, and neck.
There was no apparent erythema, telangiectasia,
freckles, atrophy, or papular lesions. Other aspects of
the dermatological examination were normal.
A skin biopsy from the hyperpigmented lesions of
the abdomen revealed mildly hyperkeratotic
epidermis along with amorphous eosinophilic masses
in the papillary dermis with haematoxylin & eosin
stain (Figure 2). The crystal violet stain demonstrated
purple colored amyloid material (Figure 3). All other
investigations (full blood count, biochemical profile,

Figure 3. Deposition of the amyloid in the papillary dermis with
histochemical examination of crystal violet (Crystal
violet ×40).

plasma protein electrophoresis, urine protein
excretion and examination for Bence-Jones protein,
chest X-ray, and abdominal ultrasound) were normal
or negative.
The patient was treated with acitretin (0.75 mg/kg
per day) for 4 months and some improvement in
hyperpigmentation was observed, and the dose was
reduced to 0.50 mg/kg per day. The patient was
continuing with the treatment at the time of writing.
Figure 1. Diffuse hyperpigmentation with numerous spotted and
hypopigmented macules that was located on the first
patient’s trunk.

Figure 2. Amorphous eosinophilic masses in the papillary dermis
with haemotoxylin & eosin stain (H&E ×100).
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Case 2
We invited the other patient’s brother to the clinic.
He was 22 years old. He had presented to hospital
many times before and had been followed up on the
basis of other diagnoses.
The lesions of the patient began in the upper
extremities 15 years before and distributed to all of
the body except the face. In the dermatological
examination we examined diffuse hyperpigmentation
with numerous spotted and hypopigmented macules
that was located on both of the lower and upper
extremities, trunk, and buttocks (Figure 4). There was
no other systemic or pathological finding. A skin
biopsy from the hyperpigmented lesions of the back
revealed mildly hyperkeratotic epidermis along with
mild (macular type) amorphous eosinophilic masses
in the papillary dermis with haemotoxylin & eosin
stain (Figure 5). The crystal violet stain demonstrated
the purple colored amyloid material.
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Figure 4. Spotted and hypopigmented macules that was located
on the second patient’s arm.

Figure 5. Similar eosinophilic masses below the epidermis in the
second patient (H&E ×100).

Same investigations carried out for the previous
patients were repeated also for this patient and no
other pathological findings were detected.

etiology of ACD, and some of the clinical overlaps
may indicate a variable penetrance (1). Cases
accompanying autoimmune connective tissue
diseases and primary biliary cirrhosis were reported
in the other primary cutaneous localized amyloid
types, such as macular and lichenoid amyloidosis (7).
However, no another systemic and dermatological
disease accompany ACD. In the literature there is only
one case accompanying generalized morphea (5).

Discussion
ADC is a rare, primary localized cutaneous type
of the amyloidosis that was firstly described by
Morishima (4). Main clinical features are dotted,
reticular hyperpigmentation with hypopigmented
spots without papulation that can be on all over the
body, minimal or no itching, onset before puberty and
small foci of amyloid closely under the epidermis (4).
Both patients had all these symptoms.
Etiopathogenesis of the disease is still not known.
It was suggested that ACD is a congenital disease and
most important factor of its etiology is sun exposure
(2,5). Moriwaki et al. suggested that genetic factors
cause ultraviolet B sensitivity and DNA repair defect;
then repeated damages to keratinocytes cause forming
of amyloid materials in the skin. Amyloid deposits
may initially be derived from cytokeratin, possibly
after keratinocyte death (6). However, in a few reports
and in our cases, there was no sun exposure history
and lesions were dense in the sunless localizations.
In the literature, there are a few reports of familial
cases (1,3). The occurrence of familial cases
accentuates the importance of genetic factors in the

Differential diagnosis of the disease should include
dyschromatosis universalis hereditaria, poikilodermalike amyloidosis, other rare forms of cutaneous
amyloidosis, xeroderma pigmentosum, vitiligo, and
macular amyloidosis, (2,6,8). Hypo- and
hyperpigmented macules are found in a generalized
distribution in the dyschromatosis universalis
hereditaria; it begins before puberty, at an average age
of 6 years old. However, histologically it can be
differentiated from ACD (9). Xeroderma
pigmentosum may have similar dyspigmentation, but
it is in photodistribution, there is evidence of
premature actinic damage, and the genetic bases are
known (10). Lentigines and hypopigmented macules
occur on dorsal aspects of hands and feet, face, and
other sun-exposed sites. Actinic damage begins in
infancy and early childhood, and skin cancers often
develop during the first decade of life (11).
Poikiloderma-like amyloidosis is associated with light
sensitivity, short stature, and blister formation or
palmoplantar hyperkeratosis (6).
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Various therapy options are found for cutaneous
amyloidosis and different results are found in the
literature. Various treatments, such as topical
corticosteroids, topical calcineurin inhibitors, UVB
phototherapy, PUVA phototherapy, dermabrasion,
keratolytics, dimethyl sulfoxide, capsaicin, and CO2
laser were used based on the symptoms observed (7).
In a previous study, successful treatment with
systemic acitretin was reported (2).

ACD can be differentiated from other primary
cutaneous amyloidoses owing to its unique and
characteristic features; and from other diseases in
the differential diagnoses through showing
deposition of amyloid. It is thought as genetic in the
etiopathogenesis due to the familial nature of the
case.
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